SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

12 Feb 2025 Evaluate
A slight decline in the revenue of Rs. 3097.70 millions was seen for the December 2024 quarter as against Rs. 3099.70 millions during year-ago period.A comparatively good net profit growth of 26.13% to Rs. 909.00 millions was reported for the quarter ended December 2024 compared to Rs. 720.70 millions of previous same quarter.Operating profit surged to 1273.90 millions from the corresponding previous quarter of 1068.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202406 202306 % Var
Sales 3097.70 3099.70 -0.06 6231.80 6149.00 1.35 11512.60 12296.20 -6.37
Other Income 39.60 51.80 -23.55 72.40 112.30 -35.53 156.30 183.90 -15.01
PBIDT 1273.90 1068.30 19.25 2447.10 2015.40 21.42 3216.30 3430.70 -6.25
Interest 1.50 1.90 -21.05 3.00 3.70 -18.92 7.20 7.70 -6.49
PBDT 1272.40 1066.40 19.32 2444.10 2011.70 21.49 3007.20 3423.00 -12.15
Depreciation 55.50 69.20 -19.80 113.20 134.00 -15.52 274.00 281.00 -2.49
PBT 1216.90 997.20 22.03 2330.90 1877.70 24.14 2733.20 3142.00 -13.01
TAX 307.90 276.50 11.36 598.60 501.30 19.41 723.40 847.30 -14.62
Deferred Tax 17.50 -19.10 -191.62 28.70 -17.20 -266.86 -86.00 -50.60 69.96
PAT 909.00 720.70 26.13 1732.30 1376.40 25.86 2009.80 2294.70 -12.42
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 41.12 34.46 19.32 39.27 32.78 19.81 27.94 27.90 0.13

Procter&Gamble Healt Share Price

5150.25 -44.30 (-0.85%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.10
Dr. Reddys Lab 1287.95
Cipla 1334.85
Zydus Lifesciences 901.65
Lupin 2350.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×